30% individuals lose Covid vaccine-acquired immunity 6 months: Study

As much as 30 per cent individuals lose vaccine-acquired immunity after six months, according to a study conducted by AIG Hospitals along with the Asian Healthcare Foundation on Vaccine Immunity.

vaccine
Press Trust of India Hyderabad
2 min read Last Updated : Jan 19 2022 | 7:01 PM IST

As much as 30 per cent individuals lose vaccine-acquired immunity after six months, according to a study conducted by AIG Hospitals along with the Asian Healthcare Foundation on Vaccine Immunity.

The study was conducted on 1,636 healthcare workers who were fully vaccinated against COVID-19, a press release from AIG Hospitals said.

"Our study results were at par with other global studies where we found that almost 30 per cent individuals had antibody levels below protective immunity level of 100 AU/ml after six months. These individuals were majorly above 40 years with co-morbidities like hypertension and diabetes. Out of the total, 6 per cent did not develop any immune protection at all," Dr D Nageshwar Reddy, Chairman, AIG Hospitals said.

The results clearly indicated that with age, immunity waning is directly proportional which means that younger people have more sustained antibody levels than the elderly population.

One of the most important results of the study showed that people above 40 years with co-morbidities like hypertension and diabetes have significantly less antibody response after six months of getting fully vaccinated, the release further said.

Individuals above 40 years with diabetes and hypertension of both genders may be at a higher risk of SARS-CoV-2 infection and these individuals should be prioritised for a booster dose after six months, AIG said.

At present, the nine-month gap for a precaution dose benefits 70 per cent of the population who can retain enough antibody levels beyond six months.

However, considering the scale of our country, the 30 per cent people especially those with co-morbid conditions like hypertension, diabetes, etc., who are more prone to develop an infection after six months of getting fully vaccinated should also be considered for the prevention dose, Dr Reddy added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsImmunity

First Published: Jan 19 2022 | 7:01 PM IST

Next Story